Peptide Chems

Wellness Research

CJC1295+Ipamorelin W/DAC
Endocrine Research10mgInvestigationalCat. 2

CJC1295+Ipamorelin W/DAC

Peptide combination studied in growth hormone secretion research.

Research Areas

Growth hormone releasing hormone (GHRH) analog studies
Pituitary function research
IGF-1 pathway investigations
Endocrine system studies

Scientific Background

CJC-1295 is a synthetic analog of growth hormone-releasing hormone (GHRH), while Ipamorelin is a growth hormone secretagogue. Scientific literature has examined their mechanisms in stimulating growth hormone release from the pituitary gland.

Deep Dive: How It Works

The 'dual-signal' concept leverages two complementary pathways: CJC-1295 binds GHRH receptors on pituitary somatotrophs, providing a sustained background signal that primes GH synthesis and storage. Ipamorelin activates ghrelin receptors (GHS-R1a), triggering acute GH release pulses from these pre-loaded somatotrophs. The DAC modification in CJC-1295 creates a covalent bond with albumin, increasing half-life from ~30 minutes to ~6-8 days. This combination mimics the natural dual-input control of GH secretion — the body normally uses both GHRH and ghrelin to regulate pulsatile GH release.

Key Insight

Ipamorelin's selectivity is what sets it apart — older GH secretagogues like GHRP-6 and Hexarelin would also elevate cortisol (stress hormone) and prolactin, creating unwanted side effects. Ipamorelin specifically targets GH release while leaving other hormonal axes undisturbed.

Optimization & Cofactors

Published research on compounds that support this peptide's mechanisms

Cofactor information is compiled from published nutritional and biochemical research. This is educational content, not supplementation advice. Consult a qualified healthcare provider.

Glycine

3g before bed

Supports GH release during sleep — enhances sleep quality and nocturnal GH pulsatility

Research Citation

Bannai et al. (2012) demonstrated glycine improves sleep quality and may enhance sleep-associated GH release

Zinc

25-30mg with lunch

Essential mineral for GH-IGF-1 axis function

Research Citation

Prasad (2013) showed zinc is required for proper GH synthesis and secretion

Vitamin D3

Morning with fatty meal

Vitamin D receptors in pituitary gland influence GH production

Research Citation

Ameri et al. (2013) found correlation between vitamin D levels and IGF-1 production

Magnesium

Glycinate form, 200-400mg before bed

Supports deep sleep phases where GH is maximally released

Research Citation

Abbasi et al. (2012) showed magnesium supplementation improves sleep quality markers

Compatibility & Stacking Guide

Research on combining peptides based on published mechanisms

Compatibility information is based on published mechanisms of action. No clinical trials have validated most combinations in humans. This is educational content only.

Compatible Compounds (Research-Based)

Tesamorelin

Both target GH axis through GHRH pathway — Tesamorelin is FDA-approved version

BPC-157

GH supports systemic recovery while BPC-157 targets local tissue repair

GHK-Cu

GH enhances systemic regeneration while GHK-Cu targets skin/tissue remodeling

Use Separately (Research-Based)

Direct GH/IGF-1

Exogenous GH suppresses endogenous GH secretion via negative feedback

Timing Guide from Published Research

Clinical research protocols administer GHRH analogs before sleep or morning fasted state. Food intake (carbs/fats) blunts GH response. Published protocols suggest 30-60min separation from meals.

Published Clinical Study Protocols

Data from peer-reviewed publications and registered clinical trials

These protocols are cited from published research for educational purposes only. They do not constitute recommendations. All research must be conducted under appropriate institutional oversight.

Prolonged GH Stimulation with CJC-1295

Teichman et al., Journal of Clinical Endocrinology & Metabolism, 2006

Protocol

Doses of 30, 60, or 125 µg/kg administered subcutaneously in healthy adults aged 21-61

Outcome

Mean GH levels increased 2-10x for 6+ days; IGF-1 elevated 1.5-3x for 14+ days with sustained dose-dependent response

Ipamorelin Selectivity Profile

Raun et al., European Journal of Endocrinology, 1998

Protocol

Various doses administered in preclinical models to compare GH, ACTH, cortisol, and prolactin responses

Outcome

Ipamorelin stimulated GH release comparable to GHRP-6 but without significant cortisol or prolactin elevation

Synergy & Cofactor Research

How this compound interacts with other molecules in research

Dual Receptor Activation

The combination targets both GHRH and ghrelin pathways simultaneously, which mirrors the body's natural GH regulation system.

Compounds Studied:CJC-1295 (GHRH analog)Ipamorelin (ghrelin agonist)
Mechanism

CJC-1295 primes somatotrophs for GH synthesis while Ipamorelin triggers release. Together, they produce more robust GH pulses than either compound alone — similar to how the hypothalamus uses both GHRH and ghrelin to regulate GH secretion.

Sleep & GH Optimization

GH secretion is naturally highest during slow-wave (deep) sleep. Research suggests GHRH activity may enhance slow-wave sleep duration.

Compounds Studied:CJC-1295 + IpamorelinSleep quality factors
Mechanism

GHRH receptor activation is associated with enhanced slow-wave sleep, which is itself the primary period for natural GH secretion. This creates a positive feedback loop between GHRH activity and GH release.

Purity & Provenance

Why quality matters for research validity

Research-grade CJC-1295 should show ≥98% purity via HPLC with mass spectrometry confirmation. The DAC component extends half-life from ~30min to ~8 days — impurities may interfere with albumin binding. Always verify COA from independent lab.

Areas of Investigation

Endocrine researchGrowth factor studiesPeptide pharmacology

Laboratory Information

Technical specifications for research settings

For Qualified Research Only

This compound is intended for qualified scientific research only. Not for human or veterinary use. Not for diagnostic or therapeutic applications. Researchers must comply with all applicable regulations in their jurisdiction.

Storage Conditions

Store at -20°C. Reconstituted solutions should be stored at 2-8°C.

Physical Form

Lyophilized powder blend

Purity

>97% by HPLC

Solubility

Soluble in bacteriostatic water for research preparation

Research Notes

For in vitro and qualified research applications only.

Published Literature

Published research has explored the pharmacokinetics and mechanisms of these peptides in laboratory settings.

Regulatory Classification

Investigational

These peptides are investigational compounds. Not available for compounding under current FDA regulations. For qualified research purposes only.

Important Research Notice

This information is compiled from scientific literature for educational purposes only. This website does not sell, distribute, or recommend any compounds for human use. All compounds discussed are for qualified research purposes only.

Related Research